Mankind Pharma Sees Significant Surge in Open Interest Amid Increased Trading Activity

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 16,218 contracts, marking a notable rise of 5,951 contracts or 57.96% from the previous open interest of 10,267. This surge in open interest coincides with a trading volume of 105,752 contracts, reflecting heightened activity in the stock.
In terms of performance, Mankind Pharma has outperformed its sector by 1.22%, continuing a positive trend with consecutive gains over the last four days, resulting in a total return of 7.51% during this period. The stock reached an intraday high of Rs 2,678, representing a 5.27% increase for the day. Furthermore, Mankind Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum.

With a market capitalization of Rs 1,07,061.84 crore, Mankind Pharma remains a liquid stock, with a delivery volume of 5.64 lakh shares on July 10, reflecting a 60% increase compared to its 5-day average delivery volume. Overall, the notable rise in open interest and robust trading metrics underscore the stock's active market presence.